NXTC
NextCure, Inc.
NextCure, Inc. (NXTC) has 2 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 3, 2026.
The most active filer is 10% Owner ADAR1 Capital Management, LLC with 5 filings. Insiders have net bought $1.6M over the trailing 6 months. The largest single insider purchase in this window was $1.3M by 10% Owner ADAR1 Capital Management, LLC on Jul 30, 2026.
- Industry:Biotechnology
- CEO:Michael S. Richman
- Employees:40
- HQ:Beltsville, MD, US
- IPO:2019-05-09
Insider Buying
$1.6M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$15.0M
latest known value
Related companies
NextCure, Inc. is in the Healthcare sector.